Results of an early-phase randomized clinical trial of a Chinese vaccine candidate based on the inactivated complete SARS-CoV-2 virus (CoronaVac) show that the formulation appears safe and induces an antibody response in healthcare volunteers aged 18 to 59 years. . The results, published Tuesday in The Lancet Infectious Diseases Journal, …
Read More »The Chinese Covid-19 vaccine is also safe and induces an immune response
